title: Introduction: Do we need multi-stakeholder colloquia in MS?
abstract: In the increasingly complex environment of MS there is a need for better cross-talk and communication between the different stakeholders who each address MS according to their own perspective.
  
  
  
  The first and second Pan-European MS Multi-stakeholder Colloquia were specifically set-up for this.
  
  
  
  In May 2014 and May 2015, the different stakeholders in MS (patients, healthcare professionals, regulators, payers and pharmaceutical industry professionals) met to present and discuss each other's perspective, formulate 10 integrated Calls to Actions (first Colloquium) and discuss guidance propositions/recommendations developed by working groups for the Calls to Action (second Colloquium).
  
  
  
  The perspectives of the different stakeholders and the 10 integrated Calls to Action are summarised in this supplement.
authors.affiliation: Department of Neurology, University of Lille, CHRU de Lille, Lille International Research Inflammation Center (LIRIC), INSRRM U995, FHU Imminent, Lille, France patrick.vermersch@univ-lille2.fr.
authors.forename: Patrick
authors.initials: P
authors.lastname: Vermersch
authors.affiliation: Managing Director at Ismar Healthcare, Lier, Belgium.
authors.forename: Louis
authors.initials: L
authors.lastname: Smets
authors.affiliation: Department of Neurology, St. Josef-Hospital Bochum, Ruhr University Bochum, Bochum, Germany.
authors.forename: Ralf
authors.initials: R
authors.lastname: Gold
mesh_terms: D003299:Cooperative Behavior; D006801:Humans; D033183:Interdisciplinary Communication; D009103:Multiple Sclerosis / Q000175:diagnosis / Q000503:physiopathology / Q000523:psychology / Q000628:therapy*; D011379:Prognosis; D058996:Quality Improvement; D019984:Quality Indicators, Health Care; D011788:Quality of Life; D000073597:Stakeholder Participation; D003226:Congresses as Topic
keywords: Multiple sclerosis; cost of illness; health; health personnel; insurance; multi-stakeholders; patients; perspective; regulators; reimbursement